Drugs / PerioSept(r)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02313883 | Jul 2015 → Jul 2018 | periodontitis | Geistlich Pharma AG | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04093895 | Aug 2019 → Jun 2020 | periodontitis | Geistlich Pharma AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PerioSept(r) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02313883 ↗ |
| Route | Other | “administration of PerioSept® 3% gel into gingival dental pockets” NCT04093895 ↗ |